Wegener's Granulomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Conditions:   Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA) Interventions:   Drug: Glucocorticoids - Standard Dose;   Drug: Glucocorticoids - Reduced Dose Sponsor:   University of Pennsylvania Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials